We are live on
!
Find out more
Vanguard Global Advisers Portfolio holdings
AUM
$215B
This Fund
S&P 500
This Quarter
Est. Return
-1.44%
1 Year Est. Return
–
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$187B
AUM Growth
–
Cap. Flow
+$194B
Cap. Flow
% of AUM
104.07%
Top 10 Holdings %
Top 10 Hldgs %
40.78%
Holding
3,683
New
3,683
Increased
–
Reduced
–
Closed
–
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard S&P 500 ETF
VOO
|
+$24.8B |
| 2 |
Vanguard Morningstar Total Stock Market ETF
VTI
|
+$12.4B |
| 3 |
NVIDIA
NVDA
|
+$9.74B |
| 4 |
Apple
AAPL
|
+$8.35B |
| 5 |
Microsoft
MSFT
|
+$6.8B |
Top Sells
No sells this quarter
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 22.86% |
| 2 | Financials | 11.48% |
| 3 | Communication Services | 7.14% |
| 4 | Consumer Discretionary | 7.01% |
| 5 | Healthcare | 6.62% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2926
SR Bancorp
SRBK
$146M
| $62.3K | ﹤0.01% |
+3,693
| New | +$62.1K |
|
|
ASIC
2927
Ategrity Specialty Insurance
ASIC
$1.18B
| $62.2K | ﹤0.01% |
+3,146
| New | +$60.9K |
|
|
ALMU
2928
Aeluma Inc
ALMU
$337M
| $61.7K | ﹤0.01% |
+4,716
| New | +$78.1K |
|
2929
Priority Technology Holdings
PRTH
$453M
| $61.4K | ﹤0.01% |
+13,009
| New | +$71.2K |
|
2930
Inhibikase Therapeutics
IKT
$336M
| $61.4K | ﹤0.01% |
+36,546
| New | +$64.9K |
|
2931
Perma-Fix Environmental Services
PESI
$369M
| $61.4K | ﹤0.01% |
+5,742
| New | +$78.9K |
|
2932
Acacia Research
ACTG
$448M
| $61.4K | ﹤0.01% |
+12,759
| New | +$53.8K |
|
2933
Foghorn Therapeutics
FHTX
$372M
| $61.3K | ﹤0.01% |
+12,833
| New | +$70.5K |
|
2934
Geospace Technologies
GEOS
$72.4M
| $61.3K | ﹤0.01% |
+5,026
| New | +$70.2K |
|
2935
TriSalus Life Sciences
TLSI
$324M
| $61.1K | ﹤0.01% |
+15,268
| New | +$74.8K |
|
|
SENEB
2936
Seneca Foods Class B
SENEB
$1.28B
| $61K | ﹤0.01% |
+409
| New | +$52K |
|
2937
ProKidney
PROK
$278M
| $61K | ﹤0.01% |
+34,074
| New | +$72.3K |
|
|
ONL
2938
Orion Office REIT
ONL
$164M
| $61K | ﹤0.01% |
+28,357
| New | +$65.7K |
|
2939
Lifecore Biomedical
LFCR
$179M
| $60.8K | ﹤0.01% |
+16,348
| New | +$113K |
|
2940
Neumora Therapeutics
NMRA
$301M
| $60.5K | ﹤0.01% |
+31,005
| New | +$80.3K |
|
2941
Precision BioSciences
DTIL
$205M
| $59.8K | ﹤0.01% |
+10,881
| New | +$50.2K |
|
2942
Spero Therapeutics
SPRO
$71.6M
| $59.5K | ﹤0.01% |
+25,446
| New | +$60.4K |
|
2943
SB Financial Group
SBFG
$170M
| $59.4K | ﹤0.01% |
+2,829
| New | +$60K |
|
2944
Orchestra BioMed
OBIO
$265M
| $59.3K | ﹤0.01% |
+13,948
| New | +$59.4K |
|
2945
Security National Financial
SNFCA
$242M
| $59.2K | ﹤0.01% |
+6,556
| New | +$56.2K |
|
2946
CB Financial Services
CBFV
$189M
| $59K | ﹤0.01% |
+1,725
| New | +$60.4K |
|
2947
Princeton Bancorp
BPRN
$296M
| $58.9K | ﹤0.01% |
+1,745
| New | +$61.1K |
|
2948
Tucows
TCX
$126M
| $58.7K | ﹤0.01% |
+3,422
| New | +$67.3K |
|
|
SEVN
2949
Seven Hills Realty Trust
SEVN
$176M
| $58.6K | ﹤0.01% |
+7,129
| New | +$61.7K |
|
|
BRT
2950
BRT Apartments
BRT
$270M
| $58.5K | ﹤0.01% |
+4,383
| New | +$63.6K |
|
Similar funds
Vanguard Global Advisers's Q1 2026 Portfolio in Review
Q1 2026 is the first quarter with a 13F filing on record for Vanguard Global Advisers, which disclosed 3,683 positions worth $187B. Its ten largest holdings account for 41% of the portfolio.
Its largest position is Vanguard S&P 500 ETF: 39,600,312 shares worth $23.7B.
By sector, the portfolio is most concentrated in Technology at 23% of assets, followed by Financials and Communication Services.
- Vanguard Global Advisers's largest Q1 2026 buy was Vanguard S&P 500 ETF: 39,600,312 shares worth $23.7B.
- Vanguard Global Advisers's ten largest holdings make up 41% of its $187B portfolio in Q1 2026.
- Vanguard Global Advisers disclosed 3,683 positions in Q1 2026, its first 13F filing on record.
Based on Vanguard Global Advisers's 13F filing for Q1 2026, filed 8 May 2026.